PMID- 31465625
OWN - NLM
STAT- MEDLINE
DCOM- 20201201
LR  - 20201201
IS  - 1520-7560 (Electronic)
IS  - 1520-7552 (Linking)
VI  - 36
IP  - 1
DP  - 2020 Jan
TI  - Probiotics for the treatment of type 2 diabetes: A review of randomized 
      controlled trials.
PG  - e3213
LID - 10.1002/dmrr.3213 [doi]
AB  - With the increasing prevalence of type 2 diabetes mellitus (T2DM), there is 
      increased interest in probiotic supplementation for improving glycaemic control. 
      This review evaluates nine randomized controlled trials that tested the effects 
      of probiotics on glycaemic outcomes including fasting plasma glucose, fasting 
      plasma insulin, haemoglobin A1c, and homeostatic model assessment of insulin 
      resistance among adults with T2DM. Based on the evidence reviewed, multistrain 
      probiotics that contain seven million to 100 billion colony forming units of 
      Lactobacillus acidophilus, Streptococcus thermophilus, Lactobacillus bulgaricus, 
      and/or Bifidobacterium lactis administered for 6 to 12 weeks may be efficacious 
      for improving glycaemic control in adults with T2DM. Further research is needed 
      to understand the role of the gut microbiota and the probiotic dose, medium, and 
      duration of exposure that is most effective for disease management.
CI  - (c) 2019 John Wiley & Sons, Ltd.
FAU - Tiderencel, Kelly A
AU  - Tiderencel KA
AUID- ORCID: 0000-0002-5580-0377
AD  - Department of Clinical and Preventive Nutrition Sciences, School of Health 
      Professions, Rutgers University, Newark, New Jersey.
FAU - Hutcheon, Deborah A
AU  - Hutcheon DA
AD  - Department of Clinical and Preventive Nutrition Sciences, School of Health 
      Professions, Rutgers University, Newark, New Jersey.
FAU - Ziegler, Jane
AU  - Ziegler J
AD  - Department of Clinical and Preventive Nutrition Sciences, School of Health 
      Professions, Rutgers University, Newark, New Jersey.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20190912
PL  - England
TA  - Diabetes Metab Res Rev
JT  - Diabetes/metabolism research and reviews
JID - 100883450
SB  - IM
MH  - Diabetes Mellitus, Type 2/*diet therapy/prevention & control
MH  - *Dietary Supplements
MH  - Humans
MH  - Probiotics/*administration & dosage
OTO - NOTNLM
OT  - diabetes mellitus
OT  - gastrointestinal microbiome
OT  - insulin resistance
OT  - metabolism
OT  - probiotics
EDAT- 2019/08/30 06:00
MHDA- 2020/12/02 06:00
CRDT- 2019/08/30 06:00
PHST- 2018/08/03 00:00 [received]
PHST- 2019/07/26 00:00 [revised]
PHST- 2019/08/19 00:00 [accepted]
PHST- 2019/08/30 06:00 [pubmed]
PHST- 2020/12/02 06:00 [medline]
PHST- 2019/08/30 06:00 [entrez]
AID - 10.1002/dmrr.3213 [doi]
PST - ppublish
SO  - Diabetes Metab Res Rev. 2020 Jan;36(1):e3213. doi: 10.1002/dmrr.3213. Epub 2019 
      Sep 12.